Medication selection and dosing often overlook genetic differences, increasing the risk of adverse reactions and ineffective treatment.
R&D Focus
AI-enabled pharmacogenomics and personalized medication selection
Innovative Solution
Neurolytic Healthcare provides personalized medicine for neurological conditions. The company delivers digitally and genomically-driven medical devices to improve the current treatment of migraine and other neurological disorders, including a diagnostic support tool, pharmacogenetic test, and a mobile app for migraine event prediction.
Neurolytic Healthcare provides personalized medicine for neurological conditions. Neurolytic Healthcare collects and extracts insights from a combination of genetic and biomarker data to enhance diagnosis and help clinicians decide on optimal treatment strategies for neurological conditions. The company delivers digitally and genomically-driven medical devices to improve the current treatment of migraine and other neurological disorders, including a diagnostic support tool, pharmacogenetic test, and a mobile app for migraine event prediction.
Products
Product
The company delivers digitally and genomically-driven medical devices to improve the current treatment of migraine and other neurological disorders, including a diagnostic support tool, pharmacogenetic test, and a mobile app for migraine event prediction.
Something missing or incorrect on this page? Help us enrich this information
